386297-59-2

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-(3-formylphenyl)benzoate is used as a reagent for the synthesis of biphenylcarboxamide compounds, which have potential applications as GPR14 antagonists or somatostatin receptor regulators. These compounds are being investigated for their therapeutic properties, offering new avenues for the treatment of various diseases and conditions.
As a reagent in the synthesis of GPR14 antagonists:
Methyl 3-(3-formylphenyl)benzoate is utilized in the development of GPR14 antagonists, which are compounds that block the action of the G protein-coupled receptor 14. These antagonists may have therapeutic applications in the treatment of neurological disorders, such as multiple sclerosis, by modulating the immune response and reducing inflammation.
As a reagent in the synthesis of somatostatin receptor regulators:
Methyl 3-(3-formylphenyl)benzoate also plays a role in the synthesis of somatostatin receptor regulators, which are compounds that interact with somatostatin receptors. These regulators have potential therapeutic applications in the treatment of various conditions, including neuroendocrine tumors, by modulating the activity of the somatostatin receptors and influencing cellular processes.